364 related articles for article (PubMed ID: 33499083)
1. TGF-β in Cancer: Metabolic Driver of the Tolerogenic Crosstalk in the Tumor Microenvironment.
Angioni R; Sánchez-Rodríguez R; Viola A; Molon B
Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33499083
[TBL] [Abstract][Full Text] [Related]
2. Tumor Microenvironment and Nitric Oxide: Concepts and Mechanisms.
Vedenko A; Panara K; Goldstein G; Ramasamy R; Arora H
Adv Exp Med Biol; 2020; 1277():143-158. PubMed ID: 33119871
[TBL] [Abstract][Full Text] [Related]
3. TGF-β: an active participant in the immune and metabolic microenvironment of multiple myeloma : TGF-β in the microenvironment of multiple myeloma.
Xue HY; Wei F
Ann Hematol; 2024 Jun; ():. PubMed ID: 38900304
[TBL] [Abstract][Full Text] [Related]
4. The Janus Face of Tumor Microenvironment Targeted by Immunotherapy.
Buoncervello M; Gabriele L; Toschi E
Int J Mol Sci; 2019 Sep; 20(17):. PubMed ID: 31484464
[TBL] [Abstract][Full Text] [Related]
5. TGF-β signaling in the tumor metabolic microenvironment and targeted therapies.
Shi X; Yang J; Deng S; Xu H; Wu D; Zeng Q; Wang S; Hu T; Wu F; Zhou H
J Hematol Oncol; 2022 Sep; 15(1):135. PubMed ID: 36115986
[TBL] [Abstract][Full Text] [Related]
6. TGF-β Mediated Immune Evasion in Cancer-Spotlight on Cancer-Associated Fibroblasts.
Ghahremanifard P; Chanda A; Bonni S; Bose P
Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33291370
[TBL] [Abstract][Full Text] [Related]
7. The Functional Crosstalk between Myeloid-Derived Suppressor Cells and Regulatory T Cells within the Immunosuppressive Tumor Microenvironment.
Haist M; Stege H; Grabbe S; Bros M
Cancers (Basel); 2021 Jan; 13(2):. PubMed ID: 33430105
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal stromal cells (MSCs) and colorectal cancer: a troublesome twosome for the anti-tumour immune response?
O'Malley G; Heijltjes M; Houston AM; Rani S; Ritter T; Egan LJ; Ryan AE
Oncotarget; 2016 Sep; 7(37):60752-60774. PubMed ID: 27542276
[TBL] [Abstract][Full Text] [Related]
9. Natural Killer Cells as Key Players of Tumor Progression and Angiogenesis: Old and Novel Tools to Divert Their Pro-Tumor Activities into Potent Anti-Tumor Effects.
Bassani B; Baci D; Gallazzi M; Poggi A; Bruno A; Mortara L
Cancers (Basel); 2019 Apr; 11(4):. PubMed ID: 30939820
[No Abstract] [Full Text] [Related]
10. GARP: A Key Target to Evaluate Tumor Immunosuppressive Microenvironment.
Bouchard A; Collin B; Garrido C; Bellaye PS; Kohli E
Biology (Basel); 2021 Aug; 10(9):. PubMed ID: 34571713
[TBL] [Abstract][Full Text] [Related]
11. A key driver to promote HCC: Cellular crosstalk in tumor microenvironment.
Liu P; Kong L; Liu Y; Li G; Xie J; Lu X
Front Oncol; 2023; 13():1135122. PubMed ID: 37007125
[TBL] [Abstract][Full Text] [Related]
12. Shaping the Immune Landscape in Cancer by Galectin-Driven Regulatory Pathways.
Rabinovich GA; Conejo-García JR
J Mol Biol; 2016 Aug; 428(16):3266-3281. PubMed ID: 27038510
[TBL] [Abstract][Full Text] [Related]
13. Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine.
Ohshio Y; Teramoto K; Hanaoka J; Tezuka N; Itoh Y; Asai T; Daigo Y; Ogasawara K
Cancer Sci; 2015 Feb; 106(2):134-42. PubMed ID: 25483888
[TBL] [Abstract][Full Text] [Related]
14. Small molecule immunomodulation: the tumor microenvironment and overcoming immune escape.
Osipov A; Saung MT; Zheng L; Murphy AG
J Immunother Cancer; 2019 Aug; 7(1):224. PubMed ID: 31439034
[TBL] [Abstract][Full Text] [Related]
15. Metabolic and functional reprogramming of myeloid-derived suppressor cells and their therapeutic control in glioblastoma.
Won WJ; Deshane JS; Leavenworth JW; Oliva CR; Griguer CE
Cell Stress; 2019 Jan; 3(2):47-65. PubMed ID: 31225500
[TBL] [Abstract][Full Text] [Related]
16. Overview: Lipid Metabolism in the Tumor Microenvironment.
Ma K; Zhang L
Adv Exp Med Biol; 2021; 1316():41-47. PubMed ID: 33740242
[TBL] [Abstract][Full Text] [Related]
17. Hitting More Birds with a Stone: Impact of TGF-β on ILC Activity in Cancer.
Fionda C; Stabile H; Cerboni C; Soriani A; Gismondi A; Cippitelli M; Santoni A
J Clin Med; 2020 Jan; 9(1):. PubMed ID: 31948072
[TBL] [Abstract][Full Text] [Related]
18. Myeloid-Derived Suppressor Cells in the Tumor Microenvironment.
Dysthe M; Parihar R
Adv Exp Med Biol; 2020; 1224():117-140. PubMed ID: 32036608
[TBL] [Abstract][Full Text] [Related]
19. The Roles of CD38 and CD157 in the Solid Tumor Microenvironment and Cancer Immunotherapy.
Wo YJ; Gan ASP; Lim X; Tay ISY; Lim S; Lim JCT; Yeong JPS
Cells; 2019 Dec; 9(1):. PubMed ID: 31861847
[TBL] [Abstract][Full Text] [Related]
20. Targeting all transforming growth factor-β isoforms with an Fc chimeric receptor impairs tumor growth and angiogenesis of oral squamous cell cancer.
Takahashi K; Akatsu Y; Podyma-Inoue KA; Matsumoto T; Takahashi H; Yoshimatsu Y; Koinuma D; Shirouzu M; Miyazono K; Watabe T
J Biol Chem; 2020 Sep; 295(36):12559-12572. PubMed ID: 32631954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
